Brucellosis and inflammatory markers: data from south-east province of Turkey

Abstract

Aim Brucellosis is the most common zoonosis in the world. It is commonly seen in developing countries and causes economic loss. Brucellosis is a major public health problem. Therefore, early diagnosis of brucellosis is very important. The current study aims to investigate WBC, CRP, ESR, NLR, PLR and MPV levels, when brucellosis was first diagnosed.Methods The study included a total of 394 patients who were enrolled at our hospital between the dates of January 2007 and June 2017. Among these patients 197 were cases of brucellosis and 197 were healthy controls.Results WBC values were statistically significantly lower in the patients with brucellosis, compared to the control group (p < 0.001). Otherwise, NLR, CRP, ESR and MPV values were statistically
significantly higher in the patients with brucellosis, compared to the control group (<0.001, 0.005, 0.001, 0.042, p values respectively). PLR values did not dif
fer statistically significantly between the groups (p = 0.468).Discussion NLR is obtained from a whole blood count. NLR increases in inflammatory conditions and this increase are regarded as a marker of systemic inflammation. In a study, it was determined that NLR values were significantly higher in the brucellosis group than the control group (p = 0.032). Mean platelet volume indicates platelet size and activity. It is also used as a marker of platelet dysfunction.
Increased MPV level is associated with thrombotic disorders and endothelial dysfunction. In the study by Aktar et al. MPV values were significantly higher in the brucellosis group than in the control group (p=0.026).Conclusion NLR and MPV have been shown to be important markers that can be used in the first diagnosis of brucellosis.

Keywords

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

View full license details →